Sources | Names Used |
---|---|
GDSC1000 | Tivozanib |
CTRPv2 | tivozanib |
PharmacoGx | tivozanib |
Database | Identifier |
---|---|
Smiles: | CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl |
Inchikey: | SPMVMDHWKHCIDT-UHFFFAOYSA-N |
Pubchem: | 9911830 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GGT5 | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-11 |
mRNA | C1QTNF4 | GDSC1000 | pan-cancer | AAC | 0.22 | 7e-11 |
mRNA | MATK | CTRPv2 | pan-cancer | AAC | 0.24 | 7e-11 |
mRNA | AC104389.1 | CTRPv2 | pan-cancer | AAC | 0.23 | 8e-11 |
mRNA | EEF1A1 | CTRPv2 | pan-cancer | AAC | 0.26 | 9e-11 |
mRNA | GAB2 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-10 |
mRNA | PLPPR3 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-10 |
mRNA | TOP1MT | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-10 |
mRNA | GOLGA8J | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-10 |
mRNA | HBG2 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-10 |